Keynote speakers presented Nevisense at the 2024 Winter Clinical Dermatology Conference in Miami
STOCKHOLM, Feb. 19, 2024 /PRNewswire/ -- SciBase Holding AB ("SciBase") [STO: SCIB], a leading developer of augmented intelligence-based solutions for skin disorders participated at the 2024 Winter Clinical Dermatology Conference in Miami.
- STOCKHOLM, Feb. 19, 2024 /PRNewswire/ -- SciBase Holding AB ("SciBase") [STO: SCIB], a leading developer of augmented intelligence-based solutions for skin disorders participated at the 2024 Winter Clinical Dermatology Conference in Miami.
- The second annual Winter Clinical Miami conference is a 4-day CME course that educates dermatologists on innovative news within Medical, and Surgical Dermatology.
- At the conference, SciBase presented its product Nevisense - an AI-powered detection enhancement technology that improves the ability for early detection of melanoma at point of care.
- Attendees had the opportunity to learn about Nevisense in the scientific sessions where Nevisense was presented and gain valuable insight on how to improve patient outcomes by integrating Nevisense into their clinical practices.